nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Topotecan—lung cancer	0.0323	0.142	CbGbCtD
Brinzolamide—CYP3A4—Gefitinib—lung cancer	0.0295	0.13	CbGbCtD
Brinzolamide—CYP3A4—Teniposide—lung cancer	0.0286	0.126	CbGbCtD
Brinzolamide—CYP3A4—Vinorelbine—lung cancer	0.0227	0.1	CbGbCtD
Brinzolamide—CYP3A4—Crizotinib—lung cancer	0.0181	0.0796	CbGbCtD
Brinzolamide—CYP3A4—Erlotinib—lung cancer	0.0174	0.0768	CbGbCtD
Brinzolamide—CYP3A4—Paclitaxel—lung cancer	0.016	0.0703	CbGbCtD
Brinzolamide—CYP3A4—Irinotecan—lung cancer	0.0158	0.0694	CbGbCtD
Brinzolamide—CYP3A4—Vinblastine—lung cancer	0.014	0.0617	CbGbCtD
Brinzolamide—CYP3A4—Etoposide—lung cancer	0.0126	0.0556	CbGbCtD
Brinzolamide—CYP3A4—Docetaxel—lung cancer	0.0115	0.0508	CbGbCtD
Brinzolamide—CYP3A4—Doxorubicin—lung cancer	0.00861	0.0379	CbGbCtD
Brinzolamide—CA5B—mammary gland—lung cancer	0.00386	0.094	CbGeAlD
Brinzolamide—CA7—trachea—lung cancer	0.00326	0.0794	CbGeAlD
Brinzolamide—CA12—respiratory system—lung cancer	0.00287	0.0698	CbGeAlD
Brinzolamide—CA14—cardiac atrium—lung cancer	0.00255	0.0622	CbGeAlD
Brinzolamide—CA1—respiratory system—lung cancer	0.00227	0.0553	CbGeAlD
Brinzolamide—CA12—trachea—lung cancer	0.00212	0.0516	CbGeAlD
Brinzolamide—CA5B—cardiac atrium—lung cancer	0.00178	0.0435	CbGeAlD
Brinzolamide—CA4—respiratory system—lung cancer	0.00177	0.0432	CbGeAlD
Brinzolamide—CA12—lung—lung cancer	0.00152	0.0371	CbGeAlD
Brinzolamide—CA2—respiratory system—lung cancer	0.00147	0.0359	CbGeAlD
Brinzolamide—CA5B—lung—lung cancer	0.00137	0.0333	CbGeAlD
Brinzolamide—CA1—bone marrow—lung cancer	0.00133	0.0324	CbGeAlD
Brinzolamide—CA4—trachea—lung cancer	0.00131	0.032	CbGeAlD
Brinzolamide—CA4—cardiac atrium—lung cancer	0.00123	0.03	CbGeAlD
Brinzolamide—CA2—epithelium—lung cancer	0.00123	0.03	CbGeAlD
Brinzolamide—CA2—bronchus—lung cancer	0.00121	0.0295	CbGeAlD
Brinzolamide—CA1—lung—lung cancer	0.00121	0.0294	CbGeAlD
Brinzolamide—CA2—trachea—lung cancer	0.00109	0.0265	CbGeAlD
Brinzolamide—CA4—bone marrow—lung cancer	0.00104	0.0253	CbGeAlD
Brinzolamide—CA2—cardiac atrium—lung cancer	0.00102	0.0249	CbGeAlD
Brinzolamide—CA4—lung—lung cancer	0.000942	0.023	CbGeAlD
Brinzolamide—CA5B—lymph node—lung cancer	0.000934	0.0228	CbGeAlD
Brinzolamide—CA2—bone marrow—lung cancer	0.000863	0.021	CbGeAlD
Brinzolamide—CA1—lymph node—lung cancer	0.000825	0.0201	CbGeAlD
Brinzolamide—CA2—lung—lung cancer	0.000781	0.019	CbGeAlD
Brinzolamide—CA4—lymph node—lung cancer	0.000645	0.0157	CbGeAlD
Brinzolamide—CA2—lymph node—lung cancer	0.000534	0.013	CbGeAlD
Brinzolamide—Nervous system disorder—Paclitaxel—lung cancer	0.000334	0.000576	CcSEcCtD
Brinzolamide—Tachycardia—Paclitaxel—lung cancer	0.000333	0.000573	CcSEcCtD
Brinzolamide—Breast disorder—Doxorubicin—lung cancer	0.000332	0.000571	CcSEcCtD
Brinzolamide—Skin disorder—Paclitaxel—lung cancer	0.000331	0.000571	CcSEcCtD
Brinzolamide—Decreased appetite—Cisplatin—lung cancer	0.00033	0.000569	CcSEcCtD
Brinzolamide—Nasopharyngitis—Doxorubicin—lung cancer	0.000328	0.000565	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000328	0.000565	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—lung cancer	0.000327	0.000563	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—lung cancer	0.000327	0.000563	CcSEcCtD
Brinzolamide—Depression—Methotrexate—lung cancer	0.000326	0.000561	CcSEcCtD
Brinzolamide—Hypotension—Etoposide—lung cancer	0.000325	0.00056	CcSEcCtD
Brinzolamide—Pain—Cisplatin—lung cancer	0.000325	0.000559	CcSEcCtD
Brinzolamide—Vomiting—Vinorelbine—lung cancer	0.000322	0.000555	CcSEcCtD
Brinzolamide—Rash—Vinorelbine—lung cancer	0.00032	0.000551	CcSEcCtD
Brinzolamide—Dermatitis—Vinorelbine—lung cancer	0.000319	0.00055	CcSEcCtD
Brinzolamide—Hypotension—Paclitaxel—lung cancer	0.000319	0.000549	CcSEcCtD
Brinzolamide—Headache—Vinorelbine—lung cancer	0.000318	0.000547	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—lung cancer	0.000317	0.000547	CcSEcCtD
Brinzolamide—Asthma—Doxorubicin—lung cancer	0.000317	0.000546	CcSEcCtD
Brinzolamide—Palpitations—Docetaxel—lung cancer	0.000313	0.000539	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—lung cancer	0.000313	0.000539	CcSEcCtD
Brinzolamide—Paraesthesia—Etoposide—lung cancer	0.000312	0.000538	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000311	0.000535	CcSEcCtD
Brinzolamide—Dyspnoea—Etoposide—lung cancer	0.00031	0.000534	CcSEcCtD
Brinzolamide—Somnolence—Etoposide—lung cancer	0.000309	0.000533	CcSEcCtD
Brinzolamide—Cough—Docetaxel—lung cancer	0.000309	0.000532	CcSEcCtD
Brinzolamide—Angina pectoris—Doxorubicin—lung cancer	0.000309	0.000532	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—lung cancer	0.000309	0.000532	CcSEcCtD
Brinzolamide—Insomnia—Paclitaxel—lung cancer	0.000308	0.000531	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—lung cancer	0.000308	0.000531	CcSEcCtD
Brinzolamide—Hypersensitivity—Irinotecan—lung cancer	0.000308	0.000531	CcSEcCtD
Brinzolamide—Paraesthesia—Paclitaxel—lung cancer	0.000306	0.000528	CcSEcCtD
Brinzolamide—Hypertension—Docetaxel—lung cancer	0.000306	0.000527	CcSEcCtD
Brinzolamide—Bronchitis—Doxorubicin—lung cancer	0.000305	0.000526	CcSEcCtD
Brinzolamide—Dyspnoea—Paclitaxel—lung cancer	0.000304	0.000524	CcSEcCtD
Brinzolamide—Somnolence—Paclitaxel—lung cancer	0.000303	0.000522	CcSEcCtD
Brinzolamide—Decreased appetite—Etoposide—lung cancer	0.000302	0.000521	CcSEcCtD
Brinzolamide—Myalgia—Docetaxel—lung cancer	0.000301	0.000519	CcSEcCtD
Brinzolamide—Arthralgia—Docetaxel—lung cancer	0.000301	0.000519	CcSEcCtD
Brinzolamide—Chest pain—Docetaxel—lung cancer	0.000301	0.000519	CcSEcCtD
Brinzolamide—Nausea—Vinorelbine—lung cancer	0.000301	0.000519	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Etoposide—lung cancer	0.0003	0.000517	CcSEcCtD
Brinzolamide—Dyspepsia—Paclitaxel—lung cancer	0.0003	0.000517	CcSEcCtD
Brinzolamide—Asthenia—Irinotecan—lung cancer	0.0003	0.000517	CcSEcCtD
Brinzolamide—Fatigue—Etoposide—lung cancer	0.0003	0.000517	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000299	0.000516	CcSEcCtD
Brinzolamide—Pain—Etoposide—lung cancer	0.000297	0.000512	CcSEcCtD
Brinzolamide—Decreased appetite—Paclitaxel—lung cancer	0.000296	0.000511	CcSEcCtD
Brinzolamide—Dry mouth—Docetaxel—lung cancer	0.000295	0.000508	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000294	0.000507	CcSEcCtD
Brinzolamide—Fatigue—Paclitaxel—lung cancer	0.000294	0.000506	CcSEcCtD
Brinzolamide—Pollakiuria—Doxorubicin—lung cancer	0.000293	0.000505	CcSEcCtD
Brinzolamide—Asthenia—Gemcitabine—lung cancer	0.000292	0.000503	CcSEcCtD
Brinzolamide—Pain—Paclitaxel—lung cancer	0.000292	0.000502	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—lung cancer	0.000291	0.000501	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—lung cancer	0.00029	0.000499	CcSEcCtD
Brinzolamide—Pruritus—Gemcitabine—lung cancer	0.000288	0.000496	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—lung cancer	0.000287	0.000495	CcSEcCtD
Brinzolamide—Infection—Docetaxel—lung cancer	0.000287	0.000495	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—lung cancer	0.000287	0.000494	CcSEcCtD
Brinzolamide—Diarrhoea—Irinotecan—lung cancer	0.000286	0.000493	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—lung cancer	0.000283	0.000488	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—lung cancer	0.000283	0.000487	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—lung cancer	0.000283	0.000487	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—lung cancer	0.000283	0.000487	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—lung cancer	0.000282	0.000486	CcSEcCtD
Brinzolamide—Feeling abnormal—Paclitaxel—lung cancer	0.000281	0.000484	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—lung cancer	0.000281	0.000484	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—lung cancer	0.00028	0.000482	CcSEcCtD
Brinzolamide—Diarrhoea—Gemcitabine—lung cancer	0.000279	0.00048	CcSEcCtD
Brinzolamide—Dizziness—Irinotecan—lung cancer	0.000276	0.000476	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—lung cancer	0.000276	0.000476	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—lung cancer	0.000275	0.000474	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—lung cancer	0.000274	0.000472	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—lung cancer	0.000273	0.000471	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—lung cancer	0.000272	0.000469	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—lung cancer	0.000272	0.000469	CcSEcCtD
Brinzolamide—Urticaria—Paclitaxel—lung cancer	0.000271	0.000467	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—lung cancer	0.00027	0.000465	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—lung cancer	0.000267	0.000461	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—lung cancer	0.000267	0.00046	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—lung cancer	0.000266	0.000458	CcSEcCtD
Brinzolamide—Vomiting—Irinotecan—lung cancer	0.000266	0.000458	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—lung cancer	0.000265	0.000457	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—lung cancer	0.000265	0.000456	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—lung cancer	0.000264	0.000455	CcSEcCtD
Brinzolamide—Rash—Irinotecan—lung cancer	0.000264	0.000454	CcSEcCtD
Brinzolamide—Dermatitis—Irinotecan—lung cancer	0.000263	0.000454	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000263	0.000454	CcSEcCtD
Brinzolamide—Headache—Irinotecan—lung cancer	0.000262	0.000451	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—lung cancer	0.000261	0.00045	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—lung cancer	0.00026	0.000447	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—lung cancer	0.00026	0.000447	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—lung cancer	0.000259	0.000446	CcSEcCtD
Brinzolamide—Vomiting—Gemcitabine—lung cancer	0.000259	0.000446	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—lung cancer	0.000258	0.000445	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—lung cancer	0.000258	0.000444	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—lung cancer	0.000257	0.000443	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—lung cancer	0.000257	0.000443	CcSEcCtD
Brinzolamide—Rash—Gemcitabine—lung cancer	0.000257	0.000442	CcSEcCtD
Brinzolamide—Dermatitis—Gemcitabine—lung cancer	0.000257	0.000442	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—lung cancer	0.000256	0.000441	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—lung cancer	0.000255	0.00044	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—lung cancer	0.000255	0.00044	CcSEcCtD
Brinzolamide—Headache—Gemcitabine—lung cancer	0.000255	0.00044	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—lung cancer	0.000255	0.000439	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—lung cancer	0.000254	0.000438	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—lung cancer	0.000253	0.000435	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—lung cancer	0.000252	0.000434	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—lung cancer	0.000251	0.000433	CcSEcCtD
Brinzolamide—Hypersensitivity—Paclitaxel—lung cancer	0.000251	0.000433	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—lung cancer	0.000251	0.000432	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—lung cancer	0.00025	0.000431	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—lung cancer	0.00025	0.000431	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.00025	0.00043	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—lung cancer	0.00025	0.00043	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—lung cancer	0.000249	0.00043	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—lung cancer	0.000249	0.000429	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—lung cancer	0.000249	0.000429	CcSEcCtD
Brinzolamide—Nausea—Irinotecan—lung cancer	0.000248	0.000428	CcSEcCtD
Brinzolamide—Pain—Docetaxel—lung cancer	0.000247	0.000426	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—lung cancer	0.000247	0.000425	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—lung cancer	0.000246	0.000424	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—lung cancer	0.000245	0.000422	CcSEcCtD
Brinzolamide—Asthenia—Paclitaxel—lung cancer	0.000245	0.000421	CcSEcCtD
Brinzolamide—Nausea—Gemcitabine—lung cancer	0.000242	0.000417	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—lung cancer	0.000241	0.000416	CcSEcCtD
Brinzolamide—Pruritus—Paclitaxel—lung cancer	0.000241	0.000416	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—lung cancer	0.000241	0.000414	CcSEcCtD
Brinzolamide—Rash—Cisplatin—lung cancer	0.000239	0.000412	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—lung cancer	0.000239	0.000412	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—lung cancer	0.000238	0.00041	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—lung cancer	0.000238	0.00041	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—lung cancer	0.000237	0.000409	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—lung cancer	0.000237	0.000408	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—lung cancer	0.000237	0.000408	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—lung cancer	0.000236	0.000406	CcSEcCtD
Brinzolamide—Diarrhoea—Paclitaxel—lung cancer	0.000233	0.000402	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—lung cancer	0.00023	0.000397	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—lung cancer	0.00023	0.000397	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—lung cancer	0.00023	0.000396	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—lung cancer	0.000229	0.000395	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—lung cancer	0.000229	0.000395	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—lung cancer	0.000229	0.000394	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—lung cancer	0.000227	0.000391	CcSEcCtD
Brinzolamide—Dizziness—Paclitaxel—lung cancer	0.000225	0.000388	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—lung cancer	0.000225	0.000388	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—lung cancer	0.000224	0.000387	CcSEcCtD
Brinzolamide—Cough—Methotrexate—lung cancer	0.000223	0.000384	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—lung cancer	0.000222	0.000383	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—lung cancer	0.000221	0.000381	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—lung cancer	0.000221	0.000381	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—lung cancer	0.000221	0.000381	CcSEcCtD
Brinzolamide—Rash—Etoposide—lung cancer	0.000219	0.000378	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—lung cancer	0.000219	0.000377	CcSEcCtD
Brinzolamide—Headache—Etoposide—lung cancer	0.000218	0.000375	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—lung cancer	0.000218	0.000375	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—lung cancer	0.000217	0.000374	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—lung cancer	0.000217	0.000374	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—lung cancer	0.000217	0.000374	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—lung cancer	0.000217	0.000374	CcSEcCtD
Brinzolamide—Vomiting—Paclitaxel—lung cancer	0.000217	0.000374	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—lung cancer	0.000216	0.000373	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000216	0.000372	CcSEcCtD
Brinzolamide—Rash—Paclitaxel—lung cancer	0.000215	0.00037	CcSEcCtD
Brinzolamide—Dermatitis—Paclitaxel—lung cancer	0.000215	0.00037	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—lung cancer	0.000215	0.00037	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—lung cancer	0.000215	0.00037	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—lung cancer	0.000214	0.000368	CcSEcCtD
Brinzolamide—Headache—Paclitaxel—lung cancer	0.000214	0.000368	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—lung cancer	0.000213	0.000367	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—lung cancer	0.000212	0.000366	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—lung cancer	0.000208	0.000359	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—lung cancer	0.000207	0.000357	CcSEcCtD
Brinzolamide—Infection—Methotrexate—lung cancer	0.000207	0.000357	CcSEcCtD
Brinzolamide—Nausea—Etoposide—lung cancer	0.000207	0.000356	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—lung cancer	0.000205	0.000353	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—lung cancer	0.000204	0.000352	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—lung cancer	0.000204	0.000352	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—lung cancer	0.000203	0.00035	CcSEcCtD
Brinzolamide—Nausea—Paclitaxel—lung cancer	0.000203	0.000349	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—lung cancer	0.000202	0.000349	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—lung cancer	0.000199	0.000343	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—lung cancer	0.000199	0.000342	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—lung cancer	0.000198	0.000341	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—lung cancer	0.000195	0.000336	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—lung cancer	0.000195	0.000335	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—lung cancer	0.000193	0.000332	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—lung cancer	0.000191	0.000329	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—lung cancer	0.000191	0.000329	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.00019	0.000327	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—lung cancer	0.000188	0.000325	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—lung cancer	0.000188	0.000324	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—lung cancer	0.000188	0.000324	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—lung cancer	0.000188	0.000324	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—lung cancer	0.000187	0.000322	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000187	0.000322	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—lung cancer	0.000186	0.00032	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—lung cancer	0.000186	0.00032	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—lung cancer	0.000185	0.000319	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—lung cancer	0.000184	0.000317	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—lung cancer	0.000184	0.000317	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—lung cancer	0.000183	0.000316	CcSEcCtD
Brinzolamide—Rash—Docetaxel—lung cancer	0.000182	0.000314	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—lung cancer	0.000182	0.000314	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—lung cancer	0.000181	0.000312	CcSEcCtD
Brinzolamide—Headache—Docetaxel—lung cancer	0.000181	0.000312	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—lung cancer	0.00018	0.00031	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—lung cancer	0.00018	0.000309	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—lung cancer	0.000179	0.000309	CcSEcCtD
Brinzolamide—Pain—Methotrexate—lung cancer	0.000178	0.000307	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—lung cancer	0.000177	0.000305	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—lung cancer	0.000176	0.000303	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—lung cancer	0.000175	0.000302	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—lung cancer	0.000172	0.000296	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—lung cancer	0.000172	0.000296	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—lung cancer	0.000169	0.00029	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—lung cancer	0.000165	0.000285	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000164	0.000283	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—lung cancer	0.000163	0.000281	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—lung cancer	0.000162	0.000279	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—lung cancer	0.000161	0.000277	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—lung cancer	0.00016	0.000276	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—lung cancer	0.000159	0.000274	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—lung cancer	0.000157	0.00027	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000156	0.000268	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—lung cancer	0.000156	0.000268	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—lung cancer	0.000154	0.000266	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—lung cancer	0.000153	0.000264	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—lung cancer	0.000149	0.000257	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—lung cancer	0.000149	0.000256	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—lung cancer	0.000147	0.000254	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—lung cancer	0.000143	0.000247	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—lung cancer	0.000143	0.000246	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—lung cancer	0.000138	0.000237	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—lung cancer	0.000133	0.000229	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—lung cancer	0.000132	0.000228	CcSEcCtD
Brinzolamide—Rash—Methotrexate—lung cancer	0.000131	0.000226	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—lung cancer	0.000131	0.000226	CcSEcCtD
Brinzolamide—Headache—Methotrexate—lung cancer	0.000131	0.000225	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—lung cancer	0.000129	0.000223	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—lung cancer	0.000128	0.00022	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—lung cancer	0.000124	0.000213	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—lung cancer	0.000123	0.000213	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—lung cancer	0.000119	0.000206	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—lung cancer	0.000115	0.000198	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—lung cancer	0.000114	0.000196	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—lung cancer	0.000114	0.000196	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—lung cancer	0.000113	0.000195	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—lung cancer	0.000107	0.000185	CcSEcCtD
Brinzolamide—CA9—Metabolism—ABCG2—lung cancer	9.74e-05	0.000643	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAT—lung cancer	9.69e-05	0.00064	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2E1—lung cancer	9.63e-05	0.000636	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HPGDS—lung cancer	9.55e-05	0.000631	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ENO2—lung cancer	9.55e-05	0.000631	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.53e-05	0.00063	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NQO1—lung cancer	9.52e-05	0.000629	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPP2R1B—lung cancer	9.49e-05	0.000627	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ABCB1—lung cancer	9.43e-05	0.000623	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.4e-05	0.000621	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1A1—lung cancer	9.37e-05	0.000619	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1A1—lung cancer	9.37e-05	0.000619	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ERCC2—lung cancer	9.29e-05	0.000614	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ERCC2—lung cancer	9.29e-05	0.000614	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—TYMS—lung cancer	9.26e-05	0.000612	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—lung cancer	9.26e-05	0.000612	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2E1—lung cancer	9.23e-05	0.00061	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2A6—lung cancer	9.15e-05	0.000605	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GCLC—lung cancer	9.15e-05	0.000605	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTM1—lung cancer	9.15e-05	0.000605	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NQO1—lung cancer	9.13e-05	0.000603	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.12e-05	0.000602	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GCLC—lung cancer	9.01e-05	0.000595	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.01e-05	0.000595	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2E1—lung cancer	8.85e-05	0.000585	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—APOA1—lung cancer	8.83e-05	0.000584	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NQO1—lung cancer	8.75e-05	0.000578	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ENO1—lung cancer	8.68e-05	0.000573	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1A1—lung cancer	8.68e-05	0.000573	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—APOA1—lung cancer	8.61e-05	0.000569	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—APOA1—lung cancer	8.61e-05	0.000569	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ERCC2—lung cancer	8.61e-05	0.000569	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—STK11—lung cancer	8.59e-05	0.000567	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—STK11—lung cancer	8.23e-05	0.000544	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—lung cancer	8.21e-05	0.000543	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CG—lung cancer	8.06e-05	0.000533	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOA1—lung cancer	8.04e-05	0.000531	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOA1—lung cancer	8.04e-05	0.000531	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTP1—lung cancer	7.94e-05	0.000525	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—STK11—lung cancer	7.89e-05	0.000521	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CG—lung cancer	7.86e-05	0.000519	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CG—lung cancer	7.86e-05	0.000519	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2E1—lung cancer	7.78e-05	0.000514	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAT—lung cancer	7.73e-05	0.000511	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.73e-05	0.00051	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NQO1—lung cancer	7.7e-05	0.000509	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—POMC—lung cancer	7.68e-05	0.000507	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.66e-05	0.000506	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTP1—lung cancer	7.62e-05	0.000503	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.56e-05	0.000499	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—lung cancer	7.52e-05	0.000497	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—lung cancer	7.52e-05	0.000497	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—POMC—lung cancer	7.48e-05	0.000494	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—POMC—lung cancer	7.48e-05	0.000494	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CREBBP—lung cancer	7.48e-05	0.000494	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOA1—lung cancer	7.45e-05	0.000492	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAT—lung cancer	7.41e-05	0.00049	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TYMS—lung cancer	7.38e-05	0.000488	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CG—lung cancer	7.34e-05	0.000485	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CG—lung cancer	7.34e-05	0.000485	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTP1—lung cancer	7.3e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—lung cancer	7.3e-05	0.000482	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CREBBP—lung cancer	7.29e-05	0.000481	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CREBBP—lung cancer	7.29e-05	0.000481	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—lung cancer	7.21e-05	0.000476	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAT—lung cancer	7.11e-05	0.000469	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—lung cancer	7.09e-05	0.000468	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TYMS—lung cancer	7.08e-05	0.000468	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—lung cancer	7e-05	0.000462	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—lung cancer	7e-05	0.000462	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—POMC—lung cancer	6.98e-05	0.000461	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—POMC—lung cancer	6.98e-05	0.000461	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—STK11—lung cancer	6.94e-05	0.000458	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—lung cancer	6.92e-05	0.000457	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—lung cancer	6.91e-05	0.000457	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—lung cancer	6.91e-05	0.000456	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—lung cancer	6.91e-05	0.000456	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ERCC2—lung cancer	6.86e-05	0.000453	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—lung cancer	6.82e-05	0.000451	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—lung cancer	6.82e-05	0.000451	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CREBBP—lung cancer	6.8e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CREBBP—lung cancer	6.8e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—lung cancer	6.8e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TYMS—lung cancer	6.79e-05	0.000449	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—lung cancer	6.71e-05	0.000443	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—lung cancer	6.63e-05	0.000438	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ERCC2—lung cancer	6.58e-05	0.000435	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—POMC—lung cancer	6.47e-05	0.000427	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—lung cancer	6.45e-05	0.000426	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—lung cancer	6.45e-05	0.000426	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—lung cancer	6.42e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—lung cancer	6.37e-05	0.000421	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—lung cancer	6.37e-05	0.000421	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—lung cancer	6.36e-05	0.00042	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.32e-05	0.000417	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ERCC2—lung cancer	6.31e-05	0.000417	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CREBBP—lung cancer	6.3e-05	0.000416	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAT—lung cancer	6.25e-05	0.000413	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.23e-05	0.000412	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—lung cancer	6.18e-05	0.000408	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—lung cancer	6.12e-05	0.000405	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—lung cancer	6.08e-05	0.000401	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—lung cancer	6.02e-05	0.000398	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—lung cancer	6.02e-05	0.000398	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—lung cancer	5.98e-05	0.000395	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMS—lung cancer	5.97e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—lung cancer	5.97e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—lung cancer	5.97e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOA1—lung cancer	5.94e-05	0.000392	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—lung cancer	5.9e-05	0.00039	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—lung cancer	5.9e-05	0.00039	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.81e-05	0.000384	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.73e-05	0.000378	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOA1—lung cancer	5.69e-05	0.000376	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—lung cancer	5.62e-05	0.000371	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—lung cancer	5.62e-05	0.000371	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—lung cancer	5.59e-05	0.000369	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—lung cancer	5.57e-05	0.000368	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—lung cancer	5.57e-05	0.000368	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ERCC2—lung cancer	5.55e-05	0.000366	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.5e-05	0.000364	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOA1—lung cancer	5.46e-05	0.000361	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.43e-05	0.000359	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—lung cancer	5.42e-05	0.000358	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—lung cancer	5.34e-05	0.000353	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—lung cancer	5.21e-05	0.000344	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—lung cancer	5.2e-05	0.000344	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—lung cancer	5.2e-05	0.000344	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—lung cancer	5.2e-05	0.000343	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—lung cancer	5.16e-05	0.000341	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—POMC—lung cancer	5.16e-05	0.000341	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—EP300—lung cancer	5.09e-05	0.000336	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CREBBP—lung cancer	5.03e-05	0.000332	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—lung cancer	4.98e-05	0.000329	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—EP300—lung cancer	4.96e-05	0.000328	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—EP300—lung cancer	4.96e-05	0.000328	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—POMC—lung cancer	4.95e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—lung cancer	4.86e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—lung cancer	4.86e-05	0.000321	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.84e-05	0.00032	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AZIN2—lung cancer	4.84e-05	0.00032	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CREBBP—lung cancer	4.82e-05	0.000318	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOA1—lung cancer	4.8e-05	0.000317	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—lung cancer	4.77e-05	0.000315	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—POMC—lung cancer	4.74e-05	0.000313	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—lung cancer	4.7e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—EP300—lung cancer	4.63e-05	0.000306	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—EP300—lung cancer	4.63e-05	0.000306	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CREBBP—lung cancer	4.62e-05	0.000305	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—lung cancer	4.57e-05	0.000302	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—lung cancer	4.51e-05	0.000298	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—lung cancer	4.5e-05	0.000297	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—lung cancer	4.38e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—lung cancer	4.38e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—lung cancer	4.32e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—EP300—lung cancer	4.29e-05	0.000284	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—POMC—lung cancer	4.17e-05	0.000275	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—lung cancer	4.15e-05	0.000274	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ATP5H—lung cancer	4.12e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—lung cancer	4.12e-05	0.000272	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—POMC—lung cancer	4.1e-05	0.000271	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CREBBP—lung cancer	4.06e-05	0.000268	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—lung cancer	3.98e-05	0.000263	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—lung cancer	3.95e-05	0.000261	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—lung cancer	3.85e-05	0.000254	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—lung cancer	3.82e-05	0.000252	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—lung cancer	3.8e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—lung cancer	3.78e-05	0.00025	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—lung cancer	3.77e-05	0.000249	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—lung cancer	3.67e-05	0.000243	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—lung cancer	3.67e-05	0.000243	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLBD1—lung cancer	3.67e-05	0.000242	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—lung cancer	3.59e-05	0.000237	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—lung cancer	3.44e-05	0.000227	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—lung cancer	3.43e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—lung cancer	3.43e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—EP300—lung cancer	3.42e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—lung cancer	3.36e-05	0.000222	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD17B10—lung cancer	3.36e-05	0.000222	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—lung cancer	3.33e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—lung cancer	3.3e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—EP300—lung cancer	3.28e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—lung cancer	3.17e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—EP300—lung cancer	3.15e-05	0.000208	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CKB—lung cancer	3.12e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—lung cancer	3.08e-05	0.000203	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—lung cancer	3e-05	0.000198	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—lung cancer	3e-05	0.000198	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CNDP2—lung cancer	2.93e-05	0.000194	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM2—lung cancer	2.93e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—lung cancer	2.9e-05	0.000192	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTMR3—lung cancer	2.85e-05	0.000189	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—lung cancer	2.8e-05	0.000185	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—lung cancer	2.8e-05	0.000185	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PGAM1—lung cancer	2.78e-05	0.000184	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—EP300—lung cancer	2.77e-05	0.000183	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2A7—lung cancer	2.65e-05	0.000175	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SDC4—lung cancer	2.6e-05	0.000172	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—lung cancer	2.59e-05	0.000171	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—lung cancer	2.53e-05	0.000167	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—lung cancer	2.43e-05	0.00016	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RRM1—lung cancer	2.36e-05	0.000156	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA3—lung cancer	2.36e-05	0.000156	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—lung cancer	2.33e-05	0.000154	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000147	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA4—lung cancer	2.16e-05	0.000143	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA2—lung cancer	2.11e-05	0.000139	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—lung cancer	2.07e-05	0.000137	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—lung cancer	2.05e-05	0.000135	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA1—lung cancer	2.03e-05	0.000134	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCC3—lung cancer	2.01e-05	0.000133	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—lung cancer	1.98e-05	0.000131	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKR1C1—lung cancer	1.95e-05	0.000129	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—lung cancer	1.9e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.89e-05	0.000125	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNG11—lung cancer	1.82e-05	0.00012	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDOA—lung cancer	1.74e-05	0.000115	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA3—lung cancer	1.68e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—lung cancer	1.67e-05	0.00011	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADCY1—lung cancer	1.64e-05	0.000108	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG2—lung cancer	1.64e-05	0.000108	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO2—lung cancer	1.61e-05	0.000106	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGDS—lung cancer	1.61e-05	0.000106	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.6e-05	0.000106	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—lung cancer	1.56e-05	0.000103	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCLC—lung cancer	1.54e-05	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.54e-05	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO1—lung cancer	1.46e-05	9.65e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.31e-05	8.66e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NQO1—lung cancer	1.3e-05	8.56e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—STK11—lung cancer	1.17e-05	7.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—lung cancer	1.08e-05	7.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAT—lung cancer	1.05e-05	6.95e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—lung cancer	1.02e-05	6.76e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMS—lung cancer	1e-05	6.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—lung cancer	9.93e-06	6.56e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—lung cancer	9.41e-06	6.22e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ERCC2—lung cancer	9.34e-06	6.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA1—lung cancer	8.08e-06	5.34e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—lung cancer	7.37e-06	4.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—POMC—lung cancer	7.02e-06	4.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CREBBP—lung cancer	6.84e-06	4.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—lung cancer	6.48e-06	4.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—lung cancer	6.4e-06	4.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—lung cancer	5.65e-06	3.73e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—lung cancer	5.6e-06	3.7e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—lung cancer	4.88e-06	3.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EP300—lung cancer	4.66e-06	3.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—lung cancer	3.44e-06	2.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—lung cancer	2.81e-06	1.86e-05	CbGpPWpGaD
